Press Releases

Press Release: December 12, 2002
TheraLife^® Eye formulation called "Best treatment" for dry, burning eyes caused by Contact lenses and LASIK surgery.

Effectiveness Established in Phase IIb Clinical Trial.

Los Altos, Calif. (December 12, 2002) - TheraLife^® Inc., an emerging leader in the discovery and development of cutting-edge therapeutic enhancement technologies, announced that the company's new oral TheraLife^® Eye formulation could bring welcome relief to as many as 60 million people with dry eyes caused by contact lens, and LASIK induced dry or burning eyes. The product's effectiveness was scientifically established in a Phase IIb clinical trial.

Contact lenses in particular causes dry eyes due to evaporation of the water content within the lenses. Symptoms include dry, irritated, burning, sandy or gritty eyes, eyestrain, headache, blurred and double vision. "The combination of reduced moistening and tear flow adversely impacts the oxygen balance of the external eye structure as well as the optical properties that keep our vision keen. The implications are even worse for contact lens wearers and who have undergone LASIK surgery."

"Dry eyes make fitting contact lenses very difficult for both soft and Gas Permeable Rigid lenses. Contact lenses are desirable because they offer convenience are of great esthetic value to patients." says Dr. Worrell, who is an Assistant Clinical Professor at the University of California, Berkeley, was previously a team eye doctor for the San Francisco Giants and vision consultant to the Oakland Athletics.

"The best available treatment that I have found for dry eyes is TheraLife^® Eye, a remarkable new formulation," said Dr. Worrell. "Taken orally, TheraLife capsules produce sustainable long-term results, good patient acceptance, contain all natural ingredients and, best of all, they work. Some eye drops, on the other hand, can actually make the dry eye condition worse."

"TheraLife^® capsules offer substantial advantages for sufferers of dry eyes by encourages the eye to secrete nature tears, rapidly relieving the discomfort of dry eyes and eye fatigue. The effectiveness was established in a recently completed Phase IIb clinical trial. Unlike eye drops, which evaporate quickly and contain potentially harmful artificial preservatives, relief with TheraLife^® Eye is quick and sustained over time. It is especially ideal for women since it won't interfere with make up." said Lily C. Yang, Ph.D., TheraLife^® CEO and President.

TheraLife^® Eye is available through your optometrists, ophthalmologists or on the web at www.theralife.com. For more information about TheraLife^® Eye, call toll free 1-877-917-1989.

About TheraLife^®
Based in Silicon Valley, California, TheraLife^® is a rapidly growing, emerging leader in the discovery and development of cutting-edge drug enhancement technologies. The company's mission is to offer superior products and breakthrough technologies that enable faster, more natural and more efficient delivery of therapeutic agents with fewer side effects.

Dr. Burton Worrell
Assistant Clinical Professor
University of California, Berkeley
Tel: (408) 267-2020
E-mail: idocburt@hotmail.com

COMPANY CONTACT:
Lily C. Yang, PhD
CEO & President
TheraLife^®, Inc.
Tel: 1-877-917-1989
E-mail: lcyang@theralife.com